Zavain is enthralled by the power of data and its counterpart, intelligence. He invests in companies that are using machine learning and AI to augment or replace physical-world functions including biology, language, manufacturing and analysis.
Zavain has led Lux’s investments in Primer, a stealth machine intelligence startup; Clarifai, which combines machine intelligence and image recognition; Capella, which is developing novel medicines based on computational insight applied to genomic data; Recursion which uses automation and Deep Learning to develop drugs for rare diseases; and Tempo Automation, which applies software and automation to electronics manufacturing.
Previously Zavain was an investor at Eric Schmidt’s Innovation Endeavors. There he sourced and led the firm’s investments in early stage technology companies including Zymergen and BlockStream. Zavain drafted the firm’s theses in Genetics, Synthetic Biology, and the Blockchain.
Prior to VC, Zavain was a founder and computer scientist. At Discovery Engine (acquired by Twitter), he engineered machine learning and AI systems across a proprietary distributed computing framework to build web scale-ranking algorithms. Zavain was also a cofounder of Fountainhop, one of the first hyper-local social networks.
Zavain holds a BS in symbolic systems and an MS in computer science from Stanford where he was a researcher in Stanford’s AI Lab. He is currently a Lecturer at Stanford and has taught quarter long seminars in Cryptocurrencies, Artificial Intelligence and Philosophy, and Venture Capital. Current course notes can be found here.
Are you Recursion ready?
Join our passionate, innovative team—and help us realize our goal of 100 treatments by 2025.